Brookline Capital Acquisition Corp (BCAC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BCAC | AZN | AMGN | GILD | VRTX |
| Company | Brookline Capital Acquisition Corp | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 10.07 | 167.08 | 443.26 | 146.60 | 545.53 |
| High | 27.74 | 170.18 | 447.03 | 148.94 | 555.69 |
| Low | 9.94 | 166.78 | 441.26 | 145.58 | 543.75 |
| Last | 22.71 | 169.66 | 442.24 | 148.77 | 552.85 |
| Change | +12.63 | +2.95 | -1.60 | +2.03 | +5.26 |
| Percent Change | +125.30% | +1.77% | -0.36% | +1.38% | +0.96% |
| Volume | 586,400 | 3,453,700 | 2,101,300 | 4,630,500 | 775,000 |
| 20-Day Average Volume | 69,480 | 4,314,700 | 2,684,620 | 6,678,985 | 1,255,030 |
| Previous | 10.08 | 166.71 | 443.84 | 146.74 | 547.59 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 10.81 | 162.67 | 413.99 | 137.63 | 512.13 |
| 20-Day Raw Stochastic | 72.42% | 75.14% | 93.26% | 99.03% | 96.85% |
| 20-Day Relative Strength | 93.64 | 51.81 | 71.68 | 66.19 | 66.17 |
| Weighted Alpha | +26.80 | -0.48 | +59.52 | +32.16 | +45.17 |
| Today's Opinion | 100% Buy | 88% Sell | 100% Buy | 40% Buy | 100% Buy |
| Yesterday's Opinion | 40% Buy | 88% Sell | 100% Buy | 40% Buy | 100% Buy |
| Last Month's Opinion | 100% Buy | 88% Sell | 100% Buy | 40% Sell | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +130.09% since 07/22/22 | +5.97% since 08/18/26 | +3.99% since 08/18/26 | +3.72% since 08/18/26 | +4.67% since 08/18/26 |
| Low | 9.68 on 07/25/22 | 161.48 on 08/20/26 | 429.38 on 08/21/26 | 143.19 on 08/20/26 | 532.55 on 08/19/26 |
| High | 27.74 on 07/29/22 | 170.18 on 08/25/26 | 447.03 on 08/25/26 | 148.97 on 08/19/26 | 555.69 on 08/25/26 |
| 1-Month | |||||
| %Chg | +123.52% since 06/29/22 | +0.24% since 07/24/26 | +17.60% since 07/24/26 | +15.05% since 07/24/26 | +15.81% since 07/24/26 |
| Low | 9.50 on 07/22/22 | 153.41 on 08/03/26 | 374.39 on 07/27/26 | 128.28 on 07/30/26 | 465.51 on 08/04/26 |
| High | 27.74 on 07/29/22 | 175.04 on 07/29/26 | 447.03 on 08/25/26 | 148.97 on 08/19/26 | 555.69 on 08/25/26 |
| 3-Month | |||||
| %Chg | +124.52% since 04/29/22 | -9.29% since 05/22/26 | +30.34% since 05/22/26 | +10.72% since 05/22/26 | +27.23% since 05/22/26 |
| Low | 9.50 on 07/22/22 | 153.41 on 08/03/26 | 322.30 on 06/02/26 | 121.39 on 06/10/26 | 420.01 on 06/03/26 |
| High | 27.74 on 07/29/22 | 196.41 on 07/02/26 | 447.03 on 08/25/26 | 148.97 on 08/19/26 | 555.69 on 08/25/26 |
| 6-Month | |||||
| %Chg | +127.10% since 01/28/22 | -17.56% since 02/25/26 | +15.07% since 02/25/26 | +1.12% since 02/25/26 | +14.45% since 02/25/26 |
| Low | 9.50 on 07/22/22 | 153.41 on 08/03/26 | 320.52 on 05/05/26 | 121.39 on 06/10/26 | 412.27 on 05/05/26 |
| High | 27.74 on 07/29/22 | 209.93 on 02/27/26 | 447.03 on 08/25/26 | 150.77 on 03/02/26 | 555.69 on 08/25/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 153,204 | 263,127,056 | 239,089,104 | 184,468,096 | 140,316,080 |
| Shares Outstanding, K | 6,746 | 1,550,908 | 540,632 | 1,239,955 | 253,805 |
| Annual Sales, $M | 0 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 12,001,300,000 |
| Annual Net Income, $M | -480,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 3,953,200,000 |
| Last Qtr Sales, $M | 0 | 15,384,000,000 | 10,054,000,000 | 7,803,000,000 | 3,333,900,000 |
| Last Qtr Income, $M | -2,457,658 | 2,507,000,000 | 2,375,000,000 | -10,496,000,000 | 1,099,800,000 |
| 60-Month Beta | -0.03 | 0.26 | 0.41 | 0.32 | 0.30 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A on 05/23/22 | 2.63 on 07/27/26 | 6.29 on 08/04/26 | -6.75 on 08/04/26 | 4.73 on 08/03/26 |
| Latest Earnings Date | 01/01/70 | 11/05/26 | 11/03/26 | 10/29/26 | 11/02/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 08/21/26 | 0.820 on 06/15/26 | N/A |
| Next Ex-Dividend Date | N/A | 02/20/26 | 08/21/26 | 09/15/26 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 17.17 | 19.84 | 0.00 | 32.17 |